(Q43038134)

12 November 2017

title

Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients (English)

1 reference

12 November 2017

Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients (English)

1 reference

1 July 2024

author name string

S. Pol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

V. Thiers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

F. Carnot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

B. Zins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

R. Romeo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

P. Berthelot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

C. Bréchot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

1 July 2024

language of work or name

English

0 references

publication date

1 May 1995

1 reference

full work available at URL

12 November 2017

https://doi.org/10.1038/ki.1995.198

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7637270

https://api.elsevier.com/content/article/PII:S008525381558962X?httpAccept=text/xml

1 July 2024

1 reference

https://api.elsevier.com/content/article/PII:S008525381558962X?httpAccept=text/plain

1 July 2024

1 reference

1 July 2024

1 reference

12 November 2017

volume

47

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

1412-1418

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1995.198

12 November 2017

exact match

0 references

cites work

Erythropoietin. Biology and clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Non-A non-B hepatitis associated with chronic liver disease in a haemodialysis unit

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Non-A, non-B hepatitis and chronic dialysis--another dilemma.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

The prevalence of hepatitis C virus antibodies among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Risk factors for dialysis-associated hepatitis C in Venezuela

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Relationship between liver histopathological changes and HBs Ag in 111 patients treated by long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Chronic hepatitis in kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Eradication of hepatitis C virus RNA after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Reinfection of liver graft by hepatitis C virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Hepatitis C serotype and response to interferon therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

There are two major types of hepatitis C virus in Japan

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.198

7 January 2021

Liver diseases and hepatic complications in renal transplant patients

4

1 reference

Outbreak of non-A, non-B hepatitis in centre haemodialysis patients: a retrospective analysis

1 July 2024

7

1 reference

Antibodies to hepatitis C virus in French blood donors

1 July 2024

14

1 reference

1 July 2024

Identifiers

DOI

10.1038/KI.1995.198

1 reference

12 November 2017

1 reference